| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 149, Issue 5 1723-1728, Copyright © 1992 by American Association of Immunologists
ARTICLES |
J Hill, TF Lindsay, F Ortiz, CG Yeh, HB Hechtman and FD Moore Jr
Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
We examined the role of C activation in ischemia reperfusion injury by inhibiting C activation in a rat model of mesenteric arterial occlusion. In anesthetized rats, 60 min of mesenteric arterial occlusion was followed by 3 h of reperfusion. PBS alone or containing soluble C receptor 1 (3 or 6 mg) was administered i.v. Controls underwent laparotomy without ischemia. Relative serum C activities were assessed by hemolytic assay, neutrophil (polymorphonuclear leukocyte) sequestration by tissue content of myeloperoxidase (MPO) activity, intestinal mucosal injury by histologic grading, lung vascular permeability by the ratio of bronchoalveolar lavage to blood concentration of radiolabeled BSA, and endothelial cell injury was quantified by measurement of plasma factor VIII-related Ag. After reperfusion, PBS-treated animals had increased intestinal MPO (0.048 +/- 0.007 U/g) compared to sham (0.022 +/- 0.005 U/g (p less than 0.05)) and intestinal mucosal injury score (2.490 +/- 0.221) compared to sham (0.331 +/- 0.045 (p less than 0.05)). Treatment with 6 mg soluble C receptor 1 15 min before reperfusion reduced intestinal MPO (0.017 +/- 0.003 U/g (p less than 0.05)) and mucosal injury (1.733 +/- 0.168 (p less than 0.05)) compared to PBS control. PBS-treated animals also demonstrated increased lung MPO (0.314 +/- 0.025 U/g vs 0.085 +/- 0.018 in sham (p less than 0.05)) and increased lung permeability (bronchoalveolar lavage/blood cpm 11.32 +/- 1.35 x 10(-3) vs sham 2.22 +/- 0.19 x 10(-3) (p less than 0.05)). Treatment with 6 mg soluble C receptor 1 15 min before reperfusion or at reperfusion reduced the lung permeability (bronchoalveolar lavage/blood cpm 3.90 +/- 0.79 x 10(-3) and 5.08 +/- 0.75, respectively (both p less than 0.05)) compared to PBS control, but did not reduce lung MPO (0.342 +/- 0.031 U/g and 0.246 +/- 0.025), respectively. Treatment with sCR1 also reduced the release of factor VIII-related Ag, 5-day mortality, and C hemolytic activity. In this model, C is a major mediator of intestinal injury and extraintestinal injury.
This article has been cited by other articles:
|
|
 |
|
  V. Ramaglia, R. Wolterman, M. de Kok, M. A. Vigar, I. Wagenaar-Bos, R. H. M. King, B. P. Morgan, and F. Baas Soluble Complement Receptor 1 Protects the Peripheral Nerve from Early Axon Loss after Injury Am. J. Pathol., April 1, 2008; 172(4): 1043 - 1052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Suber, M. C. Carroll, and F. D. Moore Jr. Innate response to self-antigen significantly exacerbates burn wound depth PNAS, March 6, 2007; 104(10): 3973 - 3977. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Chan, S. I. Ibrahim, K. Takahashi, E. Kwon, M. McCormack, A. Ezekowitz, M. C. Carroll, F. D. Moore Jr., and W. G. Austen Jr. The Differing Roles of the Classical and Mannose-Binding Lectin Complement Pathways in the Events following Skeletal Muscle Ischemia-Reperfusion J. Immunol., December 1, 2006; 177(11): 8080 - 8085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Hartwig, M. Klafs, M. Kirschfink, T. Hackert, L. Schneider, M.-M. Gebhard, M. W. Buchler, and J. Werner Interaction of complement and leukocytes in severe acute pancreatitis: potential for therapeutic intervention. Am J Physiol Gastrointest Liver Physiol, November 1, 2006; 291(5): G844 - G850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zhang, K. Takahashi, E. M. Alicot, T. Vorup-Jensen, B. Kessler, S. Thiel, J. C. Jensenius, R. A. B. Ezekowitz, F. D. Moore, and M. C. Carroll Activation of the Lectin Pathway by Natural IgM in a Model of Ischemia/Reperfusion Injury J. Immunol., October 1, 2006; 177(7): 4727 - 4734. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Patel, R. A.G. Smith, S. H. Sacks, and W. Zhou Therapeutic Strategy with a Membrane-Localizing Complement Regulator to Increase the Number of Usable Donor Organs after Prolonged Cold Storage J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1102 - 1111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zhang, E. M. Alicot, I. Chiu, J. Li, N. Verna, T. Vorup-Jensen, B. Kessler, M. Shimaoka, R. Chan, D. Friend, et al. Identification of the target self-antigens in reperfusion injury J. Exp. Med., January 23, 2006; 203(1): 141 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Fleming, R. P. Egan, C. Chai, G. Girardi, V. M. Holers, J. Salmon, M. Monestier, and G. C. Tsokos Anti-Phospholipid Antibodies Restore Mesenteric Ischemia/Reperfusion-Induced Injury in Complement Receptor 2/Complement Receptor 1-Deficient Mice J. Immunol., December 1, 2004; 173(11): 7055 - 7061. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Fleming, M. Monestier, and G. C. Tsokos Accelerated Ischemia/Reperfusion-Induced Injury in Autoimmunity-Prone Mice J. Immunol., September 15, 2004; 173(6): 4230 - 4235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. March, L. M. Proctor, M. J. Stoermer, R. Sbaglia, G. Abbenante, R. C. Reid, T. M. Woodruff, K. Wadi, N. Paczkowski, J. D. A. Tyndall, et al. Potent Cyclic Antagonists of the Complement C5a Receptor on Human Polymorphonuclear Leukocytes. Relationships between Structures and Activity Mol. Pharmacol., April 1, 2004; 65(4): 868 - 879. [Abstract] [Full Text]
|
|
|
|
|
|
M. Zhang, W. G. Austen Jr., I. Chiu, E. M. Alicot, R. Hung, M. Ma, N. Verna, M. Xu, H. B. Hechtman, F. D. Moore Jr., et al. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury PNAS, March 16, 2004; 101(11): 3886 - 3891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Pratt, M. E. Jones, J. Dong, W. Zhou, P. Chowdhury, R. A. G. Smith, and S. H. Sacks Nontransgenic Hyperexpression of a Complement Regulator in Donor Kidney Modulates Transplant Ischemia/Reperfusion Damage, Acute Rejection, and Chronic Nephropathy Am. J. Pathol., October 1, 2003; 163(4): 1457 - 1465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. C. Riedemann and P. A. Ward Complement in Ischemia Reperfusion Injury Am. J. Pathol., February 1, 2003; 162(2): 363 - 367. [Full Text] [PDF]
|
|
|
|
|
|
R. R. Reid, S. Woodcock, A. Shimabukuro-Vornhagen, W. G. Austen Jr., L. Kobzik, M. Zhang, H. B. Hechtman, F. D. Moore Jr., and M. C. Carroll Functional Activity of Natural Antibody is Altered in Cr2-Deficient Mice J. Immunol., November 15, 2002; 169(10): 5433 - 5440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Fleming, T. Shea-Donohue, J. M. Guthridge, L. Kulik, T. J. Waldschmidt, M. G. Gipson, G. C. Tsokos, and V. M. Holers Mice Deficient in Complement Receptors 1 and 2 Lack a Tissue Injury-Inducing Subset of the Natural Antibody Repertoire J. Immunol., August 15, 2002; 169(4): 2126 - 2133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. PARK, M. HAAS, P. N. CUNNINGHAM, J. J. ALEXANDER, L. BAO, J. M. GUTHRIDGE, D. M. KRAUS, V. M. HOLERS, and R. J. QUIGG Inhibiting the Complement System Does Not Reduce Injury in Renal Ischemia Reperfusion J. Am. Soc. Nephrol., July 1, 2001; 12(7): 1383 - 1390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Younger, N. Sasaki, M. D. Waite, H. N. Murray, E. F. Saleh, Z. A. Ravage, R. B. Hirschl, P. A. Ward, and G. O. Till Detrimental effects of complement activation in hemorrhagic shock J Appl Physiol, February 1, 2001; 90(2): 441 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Brock, R. G. Nie, K. A. Harris, and R. F. Potter Kupffer cell-initiated remote hepatic injury following bilateral hindlimb ischemia is complement dependent Am J Physiol Gastrointest Liver Physiol, February 1, 2001; 280(2): G279 - G284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Frenette, B. Cai, and J. G. Tidball Complement Activation Promotes Muscle Inflammation during Modified Muscle Use Am. J. Pathol., June 1, 2000; 156(6): 2103 - 2110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. McGrath, G. W. G. Wilkinson, O. B. Spiller, and B. P. Morgan Development of Adenovirus Vectors Encoding Rat Complement Regulators for Use in Therapy in Rodent Models of Inflammatory Diseases J. Immunol., December 15, 1999; 163(12): 6834 - 6840. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kyriakides, W. Austen Jr., Y. Wang, J. Favuzza, L. Kobzik, F. D. Moore Jr., and H. B. Hechtman Skeletal muscle reperfusion injury is mediated by neutrophils and the complement membrane attack complex Am J Physiol Cell Physiol, December 1, 1999; 277(6): C1263 - C1268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Huang, L. J. Kim, R. Mealey, H. C. Marsh Jr., Y. Zhang, A. J. Tenner, E. S. Connolly Jr., and D. J. Pinsky Neuronal Protection in Stroke by an sLex-Glycosylated Complement Inhibitory Protein Science, July 23, 1999; 285(5427): 595 - 599. [Abstract] [Full Text]
|
|
|
|
|
|
T. Heller, M. Hennecke, U. Baumann, J. E. Gessner, A. Meyer zu Vilsendorf, M. Baensch, F. Boulay, A. Kola, A. Klos, W. Bautsch, et al. Selection of a C5a Receptor Antagonist from Phage Libraries Attenuating the Inflammatory Response in Immune Complex Disease and Ischemia/Reperfusion Injury J. Immunol., July 15, 1999; 163(2): 985 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Williams, T. T. V. Pechet, M. R. Weiser, R. Reid, L. Kobzik, F. D. Moore Jr., M. C. Carroll, and H. B. Hechtman Intestinal reperfusion injury is mediated by IgM and complement J Appl Physiol, March 1, 1999; 86(3): 938 - 942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Bless, R. L. Warner, V. A. Padgaonkar, A. B. Lentsch, B. J. Czermak, H. Schmal, H. P. Friedl, and P. A. Ward Roles for C-X-C chemokines and C5a in lung injury after hindlimb ischemia-reperfusion Am J Physiol Lung Cell Mol Physiol, January 1, 1999; 276(1): L57 - L63. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Quigg, Y. Kozono, D. Berthiaume, A. Lim, D. J. Salant, A. Weinfeld, P. Griffin, E. Kremmer, and V. M. Holers Blockade of Antibody-Induced Glomerulonephritis with Crry-Ig, a Soluble Murine Complement Inhibitor J. Immunol., May 1, 1998; 160(9): 4553 - 4560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Makrides Therapeutic Inhibition of the Complement System Pharmacol. Rev., March 1, 1998; 50(1): 59 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Williams, M. R. Weiser, T. T. V. Pechet, L. Kobzik, F. D. Moore Jr., and H. B. Hechtman alpha 1-Acid glycoprotein reduces local and remote injuries after intestinal ischemia in the rat Am J Physiol Gastrointest Liver Physiol, November 1, 1997; 273(5): G1031 - G1035. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Xiao, M. J. Eppihimer, B. H. Willis, and D. L. Carden Complement-mediated lung injury and neutrophil retention after intestinal ischemia-reperfusion J Appl Physiol, May 1, 1997; 82(5): 1459 - 1465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Turnage, J. L. Lanoue, K. M. Kadesky, Y. Meng, and S. I. Myers Thromboxane A2 mediates increased pulmonary microvascular permeability after intestinal reperfusion J Appl Physiol, February 1, 1997; 82(2): 592 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Park, M. Haas, P. N. Cunningham, L. Bao, J. J. Alexander, and R. J. Quigg Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes Am J Physiol Renal Physiol, February 1, 2002; 282(2): F352 - F357. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
